Dr. Ângela Sousa obtained her degree in Biochemistry in 2007 from the University of Beira Interior (UBI), Portugal. In 2008, she was awarded an FCT PhD grant and spent 3 months (2009) in the Department of Pure and Applied Biochemistry at Lund University, Sweden, to explore innovative chromatographic columns developed by GE Healthcare company. In 2011, she spent 1 month at BIA Separations company in Slovenia for chemistry immobilization of amino acid ligands in monolithic chromatographic supports, and at the end of that year, she received her PhD degree in Biochemistry from UBI (Portugal). In 2012 and 2015, she was awarded two postdoctoral grants at the Health Sciences Research Centre of UBI (CICS-UBI) in Portugal. From February 2017 to August 2018, she was an invited assistant professor in the Sciences Faculty of UBI. From September 2018 to March 2023, she was contracted as a researcher (DL-57) from CICS-UBI in the Health Biotechnology area. In 2019, she received a guest researcher position and was a visiting professor at the Faculty of Pharmaceutical Sciences, UNESP. Since January 2022, she has been an invited assistant professor in the Health Sciences Faculty of UBI, and since March 2023, she has held a CEEC institutional position as an assistant researcher at CICS-UBI. Her main research interests include the implementation of new biotechnological platforms to obtain and deliver biopharmaceuticals with potential applications in DNA vaccines or gene therapy approaches.
